SCHEMBL314774

SCHEMBL314774

Oc1ncnc2nccnc12

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL314773 0.70 ADORA2A (0.32) ADORA2A
SCHEMBL2007373 0.70 ADORA2A (0.32) ADORA2A
SCHEMBL4385353 0.70 ADORA2A (0.37) ADORA2A
SCHEMBL28188932 0.70 ADORA2A (0.37) ADORA2A
SCHEMBL8082857 0.70 ADORA2A (0.32) ADORA2A
SCHEMBL2007375 0.70 ADORA2A (0.52) ADORA2A
SCHEMBL4386487 0.70 ADORA2A (0.33) ADORA2A
SCHEMBL12533979 0.70
SCHEMBL321932 0.68 ADORA2A (0.40) ADORA2A
SCHEMBL30361253 0.68 ADORA2A (0.40) ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119685022-A Buffer oxide etching solution with high etching uniformity 湖北兴福电子材料股份有限公司 2025-03-25 CN claimed
JP-11223937-A None JP disclosed
US-20260140444-A1 PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2026-05-21 US disclosed
CN-122028714-A Method for manufacturing semiconductor device and composition for coating patterned photoresist 台湾积体电路制造股份有限公司 2026-05-12 CN disclosed
CN-119685022-B Buffer oxide etching solution with high etching uniformity 湖北兴福电子材料股份有限公司 2026-05-12 CN disclosed
US-20260130180-A1 METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE AND WAFER PROTECTIVE COMPOSITION TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2026-05-07 US disclosed
US-12607937-B2 Photoresist top coating material for etching rate control TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2026-04-21 US disclosed
US-20260104643-A1 METHOD OF FORMING PHOTORESIST PATTERN TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2026-04-16 US disclosed
US-20260101726-A1 METHOD OF MANUFACTURING A SEMICONDUCTOR DEVICE AND SEMICONDUCTOR DEVICE MANUFACTURING TOOL TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2026-04-09 US disclosed
US-12566374-B2 Photoresist composition and method of manufacturing semiconductor device TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2026-03-03 US disclosed
WO-2005007718-A1 POSITIVE PHOTORESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2005-01-27 WO disclosed
WO-2005007719-A2 POSITIVE PHOTORESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2005-01-27 WO disclosed
US-20030087179-A1 Positive photoresist transfer material and method for processing surface of substrate using the transfer material FUJI PHOTO FILM CO., LTD. 2003-05-08 US disclosed
JP-H11223937-A POSITIVE PHOTOSENSITIVE RESIN COMPOSITION FUJI FILM OLIN KK 1999-08-17 JP disclosed
US-5350749-A Fungicides, insecticides and miticides DOWELANCO (US) 1994-09-27 US disclosed
WO-1993017682-A1 ANGIOTENSIN II RECEPTOR ANTAGONISTS ABBOTT LABORATORIES (US) 1993-09-16 WO disclosed
US-5034393-A Fungicides for plants DOWELANCO (US) 1991-07-23 US disclosed
EP-0414386-A1 Condensed pyrimidine derivates DowElanco (US) 1991-02-27 EP disclosed
EP-0380264-A2 Halogenation process DowElanco (US) 1990-08-01 EP disclosed
US-4183934-A NONALIURETIC DIURETICS ABBOTT LABORATORIES (US) 1980-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260140444-A1 PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE INO80C, INO80, NAT10 ADORA2A 3128/4885
US-12607937-B2 Photoresist top coating material for etching rate control ERCC1, ERCC2, RAD23B ADORA2A 584/4885
US-20260101726-A1 METHOD OF MANUFACTURING A SEMICONDUCTOR DEVICE AND SEMICONDUCTOR DEVICE MANUFACTURING TOOL PIEZO1, MYB, MAP2K4 ADORA2A 3139/4885
US-12566374-B2 Photoresist composition and method of manufacturing semiconductor device INO80C, INO80, PI4K2B ADORA2A 3397/4885
US-20260130180-A1 METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE AND WAFER PROTECTIVE COMPOSITION C9, C1S, ZKSCAN2 ADORA2A 2219/4885
US-20260104643-A1 METHOD OF FORMING PHOTORESIST PATTERN DSTN, PFAS, DNTT ADORA2A 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.